These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 32197530)
1. The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing-Remitting Multiple Sclerosis Mouse Model. Di Sante G; Amadio S; Sampaolese B; Clementi ME; Valentini M; Volonté C; Casalbore P; Ria F; Michetti F Cells; 2020 Mar; 9(3):. PubMed ID: 32197530 [TBL] [Abstract][Full Text] [Related]
2. S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis. Camponeschi C; De Carluccio M; Amadio S; Clementi ME; Sampaolese B; Volonté C; Tredicine M; Romano Spica V; Di Liddo R; Ria F; Michetti F; Di Sante G Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948360 [TBL] [Abstract][Full Text] [Related]
3. S100B Inhibitor Pentamidine Attenuates Reactive Gliosis and Reduces Neuronal Loss in a Mouse Model of Alzheimer's Disease. Cirillo C; Capoccia E; Iuvone T; Cuomo R; Sarnelli G; Steardo L; Esposito G Biomed Res Int; 2015; 2015():508342. PubMed ID: 26295040 [TBL] [Abstract][Full Text] [Related]
4. Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Petzold A; Eikelenboom MJ; Gveric D; Keir G; Chapman M; Lazeron RH; Cuzner ML; Polman CH; Uitdehaag BM; Thompson EJ; Giovannoni G Brain; 2002 Jul; 125(Pt 7):1462-73. PubMed ID: 12076997 [TBL] [Abstract][Full Text] [Related]
6. Pentamidine protects mice from cecal ligation and puncture-induced brain damage via inhibiting S100B/RAGE/NF-κB. Huang L; Zhang L; Liu Z; Zhao S; Xu D; Li L; Peng Q; Ai Y Biochem Biophys Res Commun; 2019 Sep; 517(2):221-226. PubMed ID: 31331643 [TBL] [Abstract][Full Text] [Related]
7. Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein Conformations. Cavalier MC; Ansari MI; Pierce AD; Wilder PT; McKnight LE; Raman EP; Neau DB; Bezawada P; Alasady MJ; Charpentier TH; Varney KM; Toth EA; MacKerell AD; Coop A; Weber DJ J Med Chem; 2016 Jan; 59(2):592-608. PubMed ID: 26727270 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223 [TBL] [Abstract][Full Text] [Related]
9. Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis. Tanabe S; Fujita Y; Ikuma K; Yamashita T Cell Death Dis; 2018 Oct; 9(11):1061. PubMed ID: 30333477 [TBL] [Abstract][Full Text] [Related]
10. S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis. Barateiro A; Afonso V; Santos G; Cerqueira JJ; Brites D; van Horssen J; Fernandes A Mol Neurobiol; 2016 Aug; 53(6):3976-3991. PubMed ID: 26184632 [TBL] [Abstract][Full Text] [Related]
11. Pathological findings in rats with experimental allergic encephalomyelitis. Dong M; Liu R; Guo L; Li C; Tan G APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994 [TBL] [Abstract][Full Text] [Related]
12. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. Liedtke W; Cannella B; Mazzaccaro RJ; Clements JM; Miller KM; Wucherpfennig KW; Gearing AJ; Raine CS Ann Neurol; 1998 Jul; 44(1):35-46. PubMed ID: 9667591 [TBL] [Abstract][Full Text] [Related]
13. Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE. Levy Barazany H; Barazany D; Puckett L; Blanga-Kanfi S; Borenstein-Auerbach N; Yang K; Peron JP; Weiner HL; Frenkel D Exp Neurol; 2014 May; 255():63-70. PubMed ID: 24552689 [TBL] [Abstract][Full Text] [Related]
14. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis. Hammer LA; Zagon IS; McLaughlin PJ Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234 [TBL] [Abstract][Full Text] [Related]